Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
about
Retinoids for treatment of Alzheimer's diseaseS100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivoAmyloid-β and Astrocytes Interplay in Amyloid-β Related DisordersThe Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseasesA novel S100 target conformation is revealed by the solution structure of the Ca2+-S100B-TRTK-12 complexInflammation and Alzheimer's diseaseInterleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's diseaseMechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid estersNeuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's diseaseCysteine oxidation in the mitogenic S100B protein leads to changes in phosphorylation by catalytic CKII-alpha subunit.Serum levels of S100B and NSE proteins in Alzheimer's disease patientsCalcium and S100B regulation of p53-dependent cell growth arrest and apoptosis.Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.Interleukin-1 and the immunogenetics of Alzheimer disease.The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation.The Nrf2-ARE cytoprotective pathway in astrocytes.Trisomy 21 and the brainDown's syndrome, neuroinflammation, and Alzheimer neuropathogenesis.Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy.Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression.S100beta induction of the proinflammatory cytokine interleukin-6 in neurons.Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F miceGlial cytokines in Alzheimer's disease: review and pathogenic implicationsCrosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.Activated astrocytes: a therapeutic target in Alzheimer's disease?S100B protein in neurodegenerative disorders.S100B as a marker for brain damage and blood-brain barrier disruption following exercise.Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A ReviewHuman astrocytes in the diseased brain.Effects of Oxaliplatin Treatment on the Enteric Glial Cells and Neurons in the Mouse Ileum.The fourth element targeting hypothesis of Alzheimer's disease pathogenesis and pathophysiology.In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.The S100B/RAGE Axis in Alzheimer's Disease.Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model.
P2860
Q22252919-3F41B6AE-4240-45DF-BBAE-6BC5C33E1893Q22254674-2A50F845-2016-4BF7-B7D9-B1F13B2F49CCQ26766934-61827499-9EDC-4378-9871-FE862472EEC2Q26822972-A365F737-8CB9-426D-93F2-17C7AC1ECB86Q27640155-9B3D3B35-300B-443D-9818-8E1C258943D6Q28138617-DD1C46AB-0AFD-4ECD-A8D7-90242B4ED5A4Q28216434-3F2C5CE6-0588-46C7-A1BA-7ED490787D52Q28389828-FE59661B-1DB1-4A8C-B01C-5E1A1EDCB5DAQ30054419-321B5CF4-66B9-4F3D-AFAC-7CCFD6B565D9Q30429443-40231E18-007C-4B90-B9C3-A170AE5F63CFQ33705590-B952E3D8-8EA3-4A7A-9175-EC184F8E38F6Q33775049-0FAFC5DF-ADC7-4B52-A4C4-EB054053D863Q33900383-51E36E1A-28D4-4A04-A58B-94F2ABA89D7DQ33935212-BE084268-94D0-4B25-9621-AE937CE9CCD3Q33941294-D79FE392-E48F-4089-BB16-B2E804F37563Q34013763-5C3D3395-05DB-458B-AFB5-AE70ED0B0F9FQ34106243-4B6F0F08-E3B9-4CA7-8874-F4EE8AAA820FQ34238722-DE195DA8-E7B1-452F-A2DC-D120874C648AQ34245979-D24A842B-85FB-4C62-94D3-CB5638A5FA71Q34376145-B0FBF89D-EA00-4D80-8162-B1E287B93632Q34984506-8AFF091D-C802-4600-91C8-95AFEF3B38AAQ35854503-EEBBC617-9F23-43BC-9D13-EB295752609EQ37113208-5E502301-F2C6-42EE-AD06-DF74EF5559A7Q37324201-7733D991-50C0-4163-BAB4-D371E9AEE346Q37324237-5E667892-B13D-40FE-ADEE-B4B28B4B2C40Q37332541-244706CA-5347-4BB8-A624-7DBFA6489291Q37520323-ECB15CAD-1B4C-4D83-B02A-2357990BFA1FQ37520360-922EDBD0-C200-4398-9E16-2F53E07176E4Q37602130-221FF280-8BFB-4768-9FDC-111D8DB2D0DAQ37630535-A1C3B571-3363-4E9C-BEB4-A38040A18DA1Q37837904-3F861090-B758-4FF0-AFA7-B1687B023796Q38160208-9B2F37B5-1BE3-41F1-B1F4-63D5BD9C6208Q38183363-89004F91-740F-4E04-BE91-D3678193560AQ39141123-AC430C9A-08FA-44FA-9524-1E528BFFC877Q40983000-805049F2-7C84-4CFC-BA06-DD6C64CE031FQ41440925-8120EC6F-3911-489B-A74D-66A973E8768AQ41862255-91F4CDB3-CD71-4B2B-90C2-7E0280A9AF11Q42151789-60D029B9-BBE4-47A0-9FB5-7F4B5BE103D2Q42407153-90B5D5CA-FAC4-42B2-B02D-68623B135C51Q42431184-9D9FA249-9BEB-4AFA-BCBA-554079D82E98
P2860
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
@en
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
@nl
type
label
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
@en
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
@nl
prefLabel
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
@en
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
@nl
P2093
P1476
Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe.
@en
P2093
P356
10.1016/0197-4580(92)90002-F
P577
1992-01-01T00:00:00Z